StockData
NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31

Niki BioSolutions, Inc.

Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026
$2.08+0.05 (+2.46%)

Close on Oct 19, 2026

Market cap
$16.66M
P/E (TTM)
–
Dividend yield
–

Niki BioSolutions, Inc. revenue by segment

No segment breakdown reported

Niki BioSolutions does not break out revenue by segment, region or product in the tagged data of its filings for this period type.